Nasdaq
REGN
Regeneron Pharmaceuticals, Inc.
- Health Care
- Listed 1991
- 1 day
- +0.5%
- 1 month
- +14.2%
- 1 year
- +39.1%
$772.11 · Mkt cap $79.5B · P/E 18.61
At the 6 Aug 2026 close
Nasdaq
Regeneron Pharmaceuticals, Inc.
$772.11 · Mkt cap $79.5B · P/E 18.61
At the 6 Aug 2026 close
Regeneron Pharmaceuticals, Inc. trades under the ticker REGN on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 1991. Its market capitalisation is $79.5B. The last closing price was $772.11, on 6 Aug 2026. It trades at 18.61 times its last reported annual diluted earnings per share. Over the past year the share price is +39.1%, and +14.2% over the past month. Returns are price returns and exclude dividends.
This page exists because REGN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.